Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES OPUS IN CONJUNCTION WITH ACQUISITION OF DREW TECHNOLOGIES
Mandate

VINGE ADVISES OPUS IN CONJUNCTION WITH ACQUISITION OF DREW TECHNOLOGIES

February 13, 2015

Vinge has advised Opus Group in connection with Opus Inspection, Inc.’s acquisition of all shares in Drew Technologies Inc., Michigan USA. Drew is a leading manufacturer of vehicle analysis equipment and diagnostics equipment for the vehicle inspection industry and OEM vehicle industry. The purchase price is USD 30 million (approximately SEK 250 million) plus a possible earn-out of USD 4.4 million (approximately SEK 36.5 million).  The transaction has been financed through a cash payment of USD 25 million (approximately SEK 209 million) and a directed issue in kind to the sellers of USD 5 million (approximately SEK 42 million). The transaction is expected to be completed within a thirty day period.

Vinge’s team consisted of responsible partner Anders Strid and associates Daniel Lennartsson and Frida Bäckergren.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025